Posted on February 24, 2008 by shsiong
by Susan Hsiong, PhD
More than 12 million minimally invasive vascular surgeries are done every year. These [...]
Filed under: AccessClosure, Biomaterials, Datascope, NeoMend, PEG-based Biomaterials, St. Jude Medical, Vascular Closure, biomaterial devices, vascular regeneration | Tagged: AccessClosure, biomaterial devices, catheterization, endovascular, Mynx, NeoMend, ProGEL, vascular closure devices | No Comments »
Posted on January 29, 2008 by jrowley
You have to hand it to Tengion, they are trying to tackle one of the largest challenges I can think of: producing tissue engineered organs and tissues from a patients own cells in unrelated indications (bladder, blood vessel, and kidney). While moving through clinical trials Tengion will surely be transforming patients lives with these [...]
Filed under: Biomaterials, Bioprocessing, Clinical Trials, Company Profiles, JNJ, Regenerative Medicine, Tengion, autologous, combination products, patient specific cell therapy, personalized medicine, tissue engineered product, vascular regeneration | Tagged: autologous therapies, company prifile, tissue engineering company | 3 Comments »
Posted on January 22, 2008 by jrowley
Pervasis Therapeutics announced that they have raised $9.75M to further develop their allogenic tissue engineered endothelial cell (EC) product for vascular health indications. Their Vascugel product is comprised of ECs grown in 3D collagen sponges that are implanted externally on blood vessels to prevent them from occluding. Pervasis has proven safety in a Phase I [...]
Filed under: Biomaterials, Bioprocessing, Clinical Trials, Company Profiles, Manufacturing, Pervasis, Regenerative Medicine, cell delivery, combination products, tissue engineered product, vascular regeneration | Tagged: end stage renal disease, endothelial cells, ESRD, gelfoam, tissue engineering, vascular health | No Comments »
